Lancet Infectious Diseases, 1473-3099

Journal

  1. 2020
  2. 2019
  3. SoM Study Group, Kluytmans-van den Bergh, M. F. Q., Bruijning-Verhagen, P. C. J., Vandenbroucke-Grauls, C. M. J. E., de Brauwer, E. I. G. B., Buiting, A. G. M., ... Kluytmans, J. A. J. W. (2019). Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study. Lancet Infectious Diseases, 19(10), 1069-1079. https://doi.org/10.1016/S1473-3099(19)30262-2
  4. Barug, D., Pronk, I., van Houten, M., Versteegh, F., Knol, M., Berbers, G., ... Rots, N. (2019). Early prevention of pertussis is key reply. Lancet Infectious Diseases, 19(7), 689-690. https://doi.org/10.1016/S1473-3099(19)30315-9
  5. Grillet, M. E., Hernandez-Villena, J. V., Llewellyn, M. S., Paniz-Mondolfi, A. E., Tami, A., Vincenti-Gonzalez, M. F., ... Alarcon-de Noya, B. (2019). Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region. Lancet Infectious Diseases, 19(5), e149-e161. [30757-6]. https://doi.org/10.1016/S1473-3099(18)30757-6
  6. 2018
  7. van Laarhoven, A., Dian, S., Aguirre-Gamboa, R., Avila-Pacheco, J., Ricaño-Ponce, I., Ruesen, C., ... van Crevel, R. (2018). Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study. Lancet Infectious Diseases, 18(5), 526-535. https://doi.org/10.1016/S1473-3099(18)30053-7
  8. van Beek, J., de Graaf, M., Al-Hello, H., Allen, D. J., Ambert-Balay, K., Botteldoorn, N., ... NoroNet (2018). Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network. Lancet Infectious Diseases, 18(5), 545-553. https://doi.org/10.1016/S1473-3099(18)30059-8
  9. 2017
  10. 2016
  11. de Jong, E., van Oers, J. A., Beishuizen, A., Girbes, A. R., Nijsten, M. W., & de lange, D. W. (2016). Procalcitonin to guide antibiotic stewardship in intensive care reply. Lancet Infectious Diseases, 16(8), 889-890. https://doi.org/10.1016/S1473-3099(16)30210-9
  12. 2015
  13. 2014
  14. Aiken, A. M., Allegranzi, B., Scott, J. A., Mehtar, S., Pittet, D., & Grundmann, H. (2014). Antibiotic resistance needs global solutions. Lancet Infectious Diseases, 14(7), 550-551. https://doi.org/10.1016/S1473-3099(14)70709-1
  15. 2013
  16. 2012
  17. de Smet, A. M. G. A., Kluytmans, J. A. J. W., & Bonten, M. J. M. (2012). Resistance after selective decontamination reply. Lancet Infectious Diseases, 12(3), 180-181.
  18. 2011
  19. van Ingen, J., de lange, W. C. M., Boeree, M. J., Iseman, M. D., Daley, C. L., Heifets, L. B., ... van Soolingen, D. (2011). XDR tuberculosis. Lancet Infectious Diseases, 11(8), 585-585.
  20. Andremont, A., Bonten, M., Kluytmans, J., Carmeli, Y., Cars, O., & Harbarth, S. (2011). Fighting bacterial resistance at the root: need for adapted EMEA guidelines. Lancet Infectious Diseases, 11(1), 6-8.
  21. 2010
  22. 2008
  23. Beutels, P., Scuffham, P. A., & MacIntyre, C. R. (2008). Funding of drugs: do vaccines warrant a different approach? Lancet Infectious Diseases, 8(11), 727-733.
  24. 2006
  25. 2004
  26. Van Damme, P. A., Keuter, M., Van Assen, S., DeWilde, P. C. M., & Beckers, P. J. A. (2004). Erratum: A rare case of oral leishmaniasis (Lancet Infectious Diseases (2004) 4 (53)). Lancet Infectious Diseases, 4(3), 185. https://doi.org/10.1016/S1473-3099(04)00950-8
  27. Van Damme, P. A., Keuter, M., Van Assen, S., DeWilde, P. C. M., & Beckers, P. J. A. (2004). A rare case of oral leishmaniasis. Lancet Infectious Diseases, 4(1), 53. https://doi.org/10.1016/S1473-3099(03)00861-2

ID: 1524290